Scarica l'app Stockscreener
149.62
2.35%
3.4756
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ORCL Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$146.14
Aprire:
$149.16
Volume 24 ore:
18.94M
Relative Volume:
0.68
Capitalizzazione di mercato:
$429.91B
Reddito:
$61.02B
Utile/perdita netta:
$15.61B
Rapporto P/E:
28.12
EPS:
5.3211
Flusso di cassa netto:
$-13.18B
1 W Prestazione:
-4.22%
1M Prestazione:
-15.57%
6M Prestazione:
-36.44%
1 anno Prestazione:
-11.25%
Intervallo 1D:
$147.70
$153.28
Intervallo di 1 settimana:
$138.59
$160.08
Portata 52W:
$118.86
$345.72
Oracle Corp Stock (ORCL) Company Profile
Nome
Oracle Corp
Settore
Industria
Telefono
(737) 867-1000
Indirizzo
2300 ORACLE WAY, AUSTIN, CA
Compare ORCL vs MSFT, PLTR, CRWD, SNPS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORCL
Oracle Corp
|
149.58 | 420.02B | 61.02B | 15.61B | -13.18B | 5.3211 |
|
MSFT
Microsoft Corporation
|
398.25 | 2.89T | 305.45B | 119.26B | 77.41B | 15.98 |
|
PLTR
Palantir Technologies Inc
|
134.72 | 308.14B | 4.48B | 1.63B | 2.10B | 0.6328 |
|
CRWD
Crowdstrike Holdings Inc
|
362.49 | 88.30B | 4.57B | -315.36M | 1.10B | -1.2634 |
|
SNPS
Synopsys Inc
|
449.02 | 84.32B | 7.05B | 1.34B | 1.35B | 8.0234 |
Oracle Corp Stock (ORCL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-09 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2026-02-09 | Downgrade | Melius | Buy → Hold |
| 2026-02-04 | Reiterato | BMO Capital Markets | Outperform |
| 2026-01-12 | Ripresa | Goldman | Buy |
| 2025-12-11 | Reiterato | BMO Capital Markets | Outperform |
| 2025-12-03 | Iniziato | Wells Fargo | Overweight |
| 2025-11-10 | Downgrade | Erste Group | Buy → Hold |
| 2025-10-13 | Reiterato | BMO Capital Markets | Outperform |
| 2025-10-09 | Iniziato | Robert W. Baird | Outperform |
| 2025-09-25 | Iniziato | Rothschild & Co Redburn | Sell |
| 2025-09-10 | Reiterato | BMO Capital Markets | Outperform |
| 2025-09-10 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-09-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-09-09 | Reiterato | BMO Capital Markets | Outperform |
| 2025-07-17 | Iniziato | Scotiabank | Sector Outperform |
| 2025-07-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-07-02 | Reiterato | BMO Capital Markets | Outperform |
| 2025-06-30 | Aggiornamento | Stifel | Hold → Buy |
| 2025-06-18 | Reiterato | Guggenheim | Buy |
| 2025-06-13 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2025-06-09 | Reiterato | BMO Capital Markets | Market Perform |
| 2025-04-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-03-19 | Iniziato | Stephens | Equal-Weight |
| 2025-03-11 | Reiterato | BMO Capital Markets | Market Perform |
| 2025-03-03 | Aggiornamento | Monness Crespi & Hardt | Sell → Neutral |
| 2025-01-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-20 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
| 2024-10-23 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2024-09-16 | Aggiornamento | Melius | Hold → Buy |
| 2024-09-10 | Reiterato | BMO Capital Markets | Market Perform |
| 2024-09-10 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2024-06-17 | Reiterato | BMO Capital Markets | Market Perform |
| 2024-04-18 | Iniziato | Oppenheimer | Perform |
| 2024-03-21 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-03-14 | Aggiornamento | Argus | Hold → Buy |
| 2024-03-12 | Reiterato | BMO Capital Markets | Market Perform |
| 2024-03-12 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-12-12 | Reiterato | BMO Capital Markets | Market Perform |
| 2023-11-13 | Aggiornamento | Edward Jones | Hold → Buy |
| 2023-10-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-15 | Iniziato | HSBC Securities | Buy |
| 2023-09-14 | Aggiornamento | DZ Bank | Hold → Buy |
| 2023-09-13 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-09-12 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| 2023-09-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-08-29 | Aggiornamento | UBS | Neutral → Buy |
| 2023-06-13 | Aggiornamento | Goldman | Sell → Neutral |
| 2023-06-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-04-20 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2023-03-10 | Downgrade | Societe Generale | Buy → Hold |
| 2023-01-18 | Iniziato | DA Davidson | Neutral |
| 2023-01-11 | Iniziato | Mizuho | Buy |
| 2023-01-09 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-10-21 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-10-20 | Aggiornamento | Piper Sandler | Underweight → Neutral |
| 2022-09-14 | Iniziato | Berenberg | Hold |
| 2022-08-12 | Iniziato | Guggenheim | Buy |
| 2022-06-29 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2022-06-27 | Ripresa | Goldman | Sell |
| 2022-06-14 | Reiterato | Monness Crespi & Hardt | Buy |
| 2022-04-01 | Iniziato | Daiwa Securities | Neutral |
| 2022-03-29 | Downgrade | Exane BNP Paribas | Neutral → Underperform |
| 2022-03-11 | Downgrade | Piper Sandler | Neutral → Underweight |
| 2022-03-11 | Aggiornamento | Societe Generale | Hold → Buy |
| 2021-12-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-12-15 | Aggiornamento | DZ Bank | Sell → Hold |
| 2021-12-10 | Reiterato | BMO Capital Markets | Market Perform |
| 2021-12-10 | Reiterato | Barclays | Equal Weight |
| 2021-12-10 | Reiterato | Citigroup | Neutral |
| 2021-12-10 | Reiterato | Cowen | Outperform |
| 2021-12-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2021-12-10 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-12-10 | Reiterato | Piper Sandler | Neutral |
| 2021-12-10 | Reiterato | Societe Generale | Hold |
| 2021-12-10 | Reiterato | Stifel | Hold |
| 2021-12-10 | Reiterato | UBS | Neutral |
| 2021-12-10 | Reiterato | Wolfe Research | Peer Perform |
| 2021-11-16 | Iniziato | Credit Suisse | Outperform |
| 2021-11-02 | Iniziato | Deutsche Bank | Hold |
| 2021-09-14 | Reiterato | BMO Capital Markets | Market Perform |
| 2021-09-14 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-08-10 | Downgrade | DZ Bank | Hold → Sell |
| 2021-05-10 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-04-23 | Iniziato | Wolfe Research | Peer Perform |
| 2021-04-21 | Downgrade | DZ Bank | Buy → Hold |
| 2021-04-01 | Ripresa | Wedbush | Neutral |
| 2021-03-22 | Ripresa | Evercore ISI | In-line |
| 2021-03-16 | Ripresa | Credit Suisse | Outperform |
| 2021-03-11 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-03-11 | Downgrade | Societe Generale | Buy → Hold |
| 2021-03-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-03-03 | Ripresa | Citigroup | Neutral |
| 2021-01-22 | Iniziato | Goldman | Sell |
| 2020-12-18 | Aggiornamento | Monness Crespi & Hardt | Neutral → Buy |
| 2020-12-16 | Ripresa | BofA Securities | Neutral |
| 2020-12-08 | Downgrade | Cleveland Research | Buy → Neutral |
| 2020-11-24 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Ripresa | UBS | Neutral |
| 2020-09-21 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-09-11 | Reiterato | BMO Capital Markets | Market Perform |
| 2020-09-11 | Reiterato | Barclays | Equal Weight |
| 2020-09-11 | Reiterato | Credit Suisse | Outperform |
| 2020-09-11 | Reiterato | Goldman | Buy |
| 2020-09-11 | Reiterato | Jefferies | Hold |
| 2020-09-11 | Reiterato | Morgan Stanley | Equal-Weight |
| 2020-09-11 | Reiterato | RBC Capital Mkts | Outperform |
| 2020-09-11 | Reiterato | Stifel | Hold |
| 2020-09-11 | Reiterato | Wells Fargo | Overweight |
| 2020-06-19 | Downgrade | Argus | Buy → Hold |
| 2020-06-01 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2020-03-31 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-20 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-03-13 | Reiterato | BMO Capital Markets | Market Perform |
Mostra tutto
Oracle Corp Borsa (ORCL) Ultime notizie
Buy Oracle Stock, Analyst Says. Here’s Why. - Barron's
Oracle Upgraded to Buy at Oppenheimer After Selloff - GuruFocus
Oracle Stock Is Climbing Today: What's Happening? - Benzinga
Oracle stock jumps after Oppenheimer upgrade — what’s next for ORCL - TechStock²
Why Oracle stock is up around 3% today - Invezz
Oracle Lawsuit Puts AI Infrastructure Spending And Disclosure Risks In Focus - Yahoo Finance
Oracle’s AI Pain May Be Over. Buy the Stock, Analysts Say. - Barron's
Is Oracle Stock Losing Its AI Edge? - Forbes
Oracle (ORCL) Upgraded by Oppenheimer with Strong EPS Growth Out - GuruFocus
Oracle's Stock Selloff Offers a Chance to Buy an 'Upper-echelon' Growth Play for Cheap: Analyst - 富途牛牛
Oracle’s selloff offers a chance to buy an ‘upper-echelon’ growth stock for cheap: analyst - MarketWatch
SC&H Expands Oracle Cloud Capabilities with Addition of Industry Veteran Rich Reid - citybiz
Oracle and Netflix among market cap stock movers on Wednesday By Investing.com - Investing.com Canada
Oracle and Netflix among market cap stock movers on Wednesday - Investing.com
Oracle's stock rises after upgrade at Oppenheimer - Seeking Alpha
Oracle Stock Upgraded To Buy As Analyst Sees Upside Following Sell Off - Investor's Business Daily
Oppenheimer upgrades Oracle stock rating on AI strength, sets $185 target - Investing.com Nigeria
Oracle upgraded, Workday downgraded: Wall Street's top analyst calls - Yahoo Finance
Ellison family's media empire expands: Oracle owner now targets Warner Bros. Discovery - Yeni Safak English
Oracle Stock Too Cheap to Ignore. Buy the Dip, Says Analyst. - Barron's
Oracle (NYSE:ORCL) Upgraded to "Outperform" at Oppenheimer - MarketBeat
Oracle Corporation $ORCL Shares Bought by TD Asset Management Inc - MarketBeat
Weitz Investment Management Inc. Sells 100,075 Shares of Oracle Corporation $ORCL - MarketBeat
Oppenheimer Upgrades Oracle (ORCL) - Nasdaq
Expert Outlook: Oracle Through The Eyes Of 27 Analysts - Benzinga
Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More - 24/7 Wall St.
Is Oracle Stock a Millionaire Maker? - AOL.com
Is Oracle Stock a Millionaire Maker? - The Motley Fool
The Risk Factors to Watch Out For in Oracle Stock - Trefis
Bradley Foster & Sargent Inc. CT Increases Stake in Oracle Corporation $ORCL - MarketBeat
Southeast Georgia Health transforms healthcare with Oracle Cloud Infrastructure - Trending Now Infrastructure
Oracle Shares Face Sustained Headwinds Amid Strategic Challenges - AD HOC NEWS
3 Forces That Could Shake Oracle Stock - Trefis
Oracle Faces Mounting Legal Challenges Amidst Ambitious Cloud Push - AD HOC NEWS
ORACLE CORPORATION (ORCL) DEADLINE ALERT Bernstein Liebhard LLP Reminds Oracle Corporation Investors of Upcoming Deadline - ACCESS Newswire
Driving innovation in AI transformation and multicloud - Oracle
Oracle Lawsuits Put AI Data Center Spending And OpenAI Ties Under Review - simplywall.st
Oracle stock price rebounds, but ORCL dips after hours as Stargate doubts linger - TechStock²
Oracle's AI Ambition: A High-Stakes Investment Strategy - AD HOC NEWS
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Oracle Corporation Investors to Secure ... - Bluefield Daily Telegraph
Oracle Corporation (NYSE: ORCL) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face April 6, 2026, Deadline - The Globe and Mail
Oracle (ORCL) Sees Light Options Activity Amid Share Price Incre - GuruFocus
VoltaGrid Weighing Public Listing or Sale, Riding the AI Wave - Bloomberg.com
Lawsuit filed for Investors who lost money with shares of Oracle Corporation (NYSE: ORCL) - openPR.com
Oracle stock price rebounds after Stargate jitters, but the next test is coming fast - TechStock²
After brutal selloffs, IBM and Oracle get a glimmer of hope from Anthropic news - Sherwood News
The Zacks Analyst Blog Highlights Oracle, Intuitive Surgical, Analog Devices and Moving iMage Technologies - Yahoo Finance
Oracle Stock: Is ORCL Underperforming the Technology Sector? - Barchart.com
Oracle Faces Investor Lawsuit Amid Tech Sector Sell-Off - AD HOC NEWS
ORCL Investors Have Opportunity to Lead Oracle Corporation Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Oracle Stock Plunges 10% on CapEx Panic: Why the $523B Backlog Justifies a $731 Target - TIKR.com
Oracle Corp Azioni (ORCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):